Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery ...

Sanford Burnham Prebys is one of several institutions contributing to the federally funded project called PREDICTS ...

Crops increasingly need to thrive in a broader range of conditions, including drought, salinity, and heat. Traditional plant ...

Triazoles are privileged five-membered aromatic heterocycles featuring three consecutive nitrogen atoms, and have emerged as versatile scaffolds in ...

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone.

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.